Published in Clin Gastroenterol Hepatol on January 26, 2007
Hereditary and familial colon cancer. Gastroenterology (2010) 4.15
ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes. Am J Gastroenterol (2015) 3.19
Inherited colorectal cancer syndromes. Cancer J (2011) 1.06
Thyroid cancer complicating familial adenomatous polyposis: mutation spectrum of at-risk individuals. Hered Cancer Clin Pract (2013) 0.91
Cribriform-morular variant of papillary thyroid carcinoma: an indication to screen for occult FAP. Fam Cancer (2014) 0.85
Familial follicular cell-derived thyroid carcinoma. Front Endocrinol (Lausanne) (2012) 0.81
Identification of patients at risk for hereditary colorectal cancer. Clin Colon Rectal Surg (2012) 0.79
Risk of thyroid cancer among Caribbean Hispanic patients with familial adenomatous polyposis. Fam Cancer (2016) 0.77
The clinical management in familial adenomatous polyposis deserves continuous monitoring for thyroid carcinoma. BMJ Case Rep (2012) 0.75
Lower gastrointestinal tract cancer predisposition syndromes. Hematol Oncol Clin North Am (2010) 0.75
FAP Associated Papillary Thyroid Carcinoma: A Peculiar Subtype of Familial Nonmedullary Thyroid Cancer. Patholog Res Int (2015) 0.75
Hereditary Colorectal Polyposis and Cancer Syndromes: A Primer on Diagnosis and Management. Am J Gastroenterol (2017) 0.75
A study of Galactin-3 on fine needle aspiration as a diagnostic marker differentiating benign from malignant thyroid neoplasm. Pak J Med Sci (2017) 0.75
Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer. Nat Med (2004) 9.80
Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA (2004) 8.12
Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol (2008) 7.65
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
Age-dependent effects of RPE65 gene therapy for Leber's congenital amaurosis: a phase 1 dose-escalation trial. Lancet (2009) 6.71
Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells. Nat Med (2005) 4.27
Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J Clin Oncol (2005) 3.83
Cowden syndrome and the PTEN hamartoma tumor syndrome: systematic review and revised diagnostic criteria. J Natl Cancer Inst (2013) 3.64
Efficacy, safety, and biomarkers of neoadjuvant bevacizumab, radiation therapy, and fluorouracil in rectal cancer: a multidisciplinary phase II study. J Clin Oncol (2009) 3.39
Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-immune microenvironment. Cell Host Microbe (2013) 3.21
Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research. J Med Genet (2010) 3.15
AAV2 gene therapy readministration in three adults with congenital blindness. Sci Transl Med (2012) 2.87
An integrative genomics approach identifies Hypoxia Inducible Factor-1 (HIF-1)-target genes that form the core response to hypoxia. Nucleic Acids Res (2009) 2.69
The chromosomal instability pathway in colon cancer. Gastroenterology (2010) 2.59
A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A (2008) 2.58
Five-year efficacy and safety analysis of the Adenoma Prevention with Celecoxib Trial. Cancer Prev Res (Phila) (2009) 2.46
A phase II study of gefitinib in patients with advanced thyroid cancer. Thyroid (2008) 2.41
Low rate of microsatellite instability in young patients with adenomas: reassessing the Bethesda guidelines. Am J Gastroenterol (2005) 2.40
Subclinical thyroid disease: clinical applications. JAMA (2004) 1.92
Hypoxia-inducible factor-1-independent regulation of vascular endothelial growth factor by hypoxia in colon cancer. Cancer Res (2004) 1.76
Priorities for improving the management of gastroenteropancreatic neuroendocrine tumors. J Natl Cancer Inst (2008) 1.71
Facilitating informed decisions regarding microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. J Clin Oncol (2010) 1.69
Prophylactic total gastrectomy for individuals with germline CDH1 mutation. Surgery (2010) 1.67
The Cables gene on chromosome 18Q regulates colon cancer progression in vivo. Cancer Biol Ther (2005) 1.65
Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Cancer Res (2009) 1.64
AAV-mediated gene therapy for choroideremia: preclinical studies in personalized models. PLoS One (2013) 1.62
Design of the liraglutide effect and action in diabetes: evaluation of cardiovascular outcome results (LEADER) trial. Am Heart J (2013) 1.62
LKB1--a master tumour suppressor of the small intestine and beyond. Nat Rev Cancer (2002) 1.62
Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet (2003) 1.59
Tumor-specific p73 up-regulation mediates p63 dependence in squamous cell carcinoma. Cancer Res (2006) 1.59
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors. Nat Genet (2013) 1.56
HIF-1alpha and HIF-2alpha have divergent roles in colon cancer. Int J Cancer (2009) 1.54
Mechanisms of Cables 1 gene inactivation in human ovarian cancer development. Cancer Biol Ther (2007) 1.54
The human visual cortex responds to gene therapy-mediated recovery of retinal function. J Clin Invest (2011) 1.52
HIF1A overexpression is associated with poor prognosis in a cohort of 731 colorectal cancers. Am J Pathol (2010) 1.48
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal. J Clin Endocrinol Metab (2006) 1.45
Hypoxia inducible factor-1 independent pathways in tumor angiogenesis. Clin Cancer Res (2007) 1.44
Oncogenic K-ras stimulates Wnt signaling in colon cancer through inhibition of GSK-3beta. Gastroenterology (2005) 1.43
GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide. J Clin Endocrinol Metab (2011) 1.40
The thyrotropin reference range should remain unchanged. J Clin Endocrinol Metab (2005) 1.30
Epithelial to mesenchymal transition is impaired in colon cancer cells with microsatellite instability. Gastroenterology (2009) 1.30
Hedgehog promotes neovascularization in pancreatic cancers by regulating Ang-1 and IGF-1 expression in bone-marrow derived pro-angiogenic cells. PLoS One (2010) 1.21
Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes (2005) 1.20
Sharing genetic test results in Lynch syndrome: communication with close and distant relatives. Clin Gastroenterol Hepatol (2008) 1.20
Dissecting genetic heterogeneity in autoimmune thyroid diseases by subset analysis. J Autoimmun (2007) 1.18
Cystic lymph node metastases in papillary thyroid carcinoma. AJR Am J Roentgenol (2002) 1.16
Thyroid carcinoma. J Natl Compr Canc Netw (2007) 1.13
Annual financial impact of well-differentiated thyroid cancer care in the United States. Cancer (2014) 1.13
Hypoxic regulation of vascular endothelial growth factor through the induction of phosphatidylinositol 3-kinase/Rho/ROCK and c-Myc. J Biol Chem (2006) 1.13
A safety and survival analysis of neoadjuvant bevacizumab with standard chemoradiation in a phase I/II study compared with standard chemoradiation in locally advanced rectal cancer. Oncologist (2010) 1.11
Genetic and biological subgroups of low-stage follicular thyroid cancer. Am J Pathol (2003) 1.11
Defining molecular classifications and targets in gastroenteropancreatic neuroendocrine tumors through DNA microarray analysis. Endocr Relat Cancer (2008) 1.11
Gβ3 is required for normal light ON responses and synaptic maintenance. J Neurosci (2012) 1.10
Oncogenic KRAS and BRAF differentially regulate hypoxia-inducible factor-1alpha and -2alpha in colon cancer. Cancer Res (2009) 1.10
Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. Cancer Res (2010) 1.08
FGFR2 signaling underlies p63 oncogenic function in squamous cell carcinoma. J Clin Invest (2013) 1.07
Thyroid carcinoma. J Natl Compr Canc Netw (2005) 1.04
Microsatellite instability in the management of colorectal cancer. Expert Rev Gastroenterol Hepatol (2011) 1.04
Prevalence and predictors of appropriate colorectal cancer surveillance in Lynch syndrome. Am J Gastroenterol (2010) 1.03
Molecular genetics of neuroendocrine tumors. Best Pract Res Clin Endocrinol Metab (2007) 1.03
Ultrasound-guided percutaneous thyroid nodule core biopsy: clinical utility in patients with prior nondiagnostic fine-needle aspirate. Thyroid (2012) 1.03
Gene transfer to ocular stem cells by early gestational intraamniotic injection of lentiviral vector. Mol Ther (2007) 1.02
Assessment of clinical practices among cancer genetic counselors. Fam Cancer (2010) 1.01
Elevation of thyroid cancer risk among cutaneous melanoma survivors. Int J Cancer (2006) 1.01
Sonic hedgehog derived from human pancreatic cancer cells augments angiogenic function of endothelial progenitor cells. Cancer Sci (2008) 1.01
Knowledge and attitudes about microsatellite instability testing among high-risk individuals diagnosed with colorectal cancer. Cancer Epidemiol Biomarkers Prev (2007) 1.00
The management of small polyps found by virtual colonoscopy: results of a decision analysis. Clin Gastroenterol Hepatol (2007) 0.99
Germline mutations in oncogene-induced senescence pathways are associated with multiple sessile serrated adenomas. Gastroenterology (2014) 0.99
BRAF V600E status adds incremental value to current risk classification systems in predicting papillary thyroid carcinoma recurrence. Surgery (2012) 0.99
Orbital radiotherapy for Graves' ophthalmopathy. Thyroid (2002) 0.98
Pediatric non-orbital pseudotumor of the head and neck. Int J Pediatr Otorhinolaryngol (2003) 0.98
Autoimmune thyroid disease. Curr Opin Rheumatol (2012) 0.97
Hypoxia activates the K-ras proto-oncogene to stimulate angiogenesis and inhibit apoptosis in colon cancer cells. PLoS One (2010) 0.97
Medullary carcinoma. J Natl Compr Canc Netw (2010) 0.97
Acute thyrotoxicosis secondary to destructive thyroiditis associated with cardiac catheterization contrast dye. Thyroid (2011) 0.97
Deficient DNA mismatch repair is common in Lynch syndrome-associated colorectal adenomas. J Mol Diagn (2009) 0.96
Carbon dioxide laser fiber for laryngeal cancer surgery. Ann Otol Rhinol Laryngol (2006) 0.96
Colorectal cancer risk perception on the basis of genetic test results in individuals at risk for Lynch syndrome. J Clin Oncol (2009) 0.96
Healthy women with a family history of breast cancer: impact of a tailored genetic counseling intervention on risk perception, knowledge, and menopausal therapy decision making. J Womens Health (Larchmt) (2006) 0.95
Thyroid-associated paragangliomas. Thyroid (2011) 0.95
Hereditary colon cancer syndromes. Semin Oncol (2011) 0.95
Case records of the Massachusetts General Hospital. Case 22-2007. A woman with a family history of gastric and breast cancer. N Engl J Med (2007) 0.95
Impact of genetic testing on endometrial cancer risk-reducing practices in women at risk for Lynch syndrome. Gynecol Oncol (2012) 0.94
The Cables gene on chromosome 18q is silenced by promoter hypermethylation and allelic loss in human colorectal cancer. Am J Pathol (2007) 0.94
A novel PHOX2A/ARIX mutation in an Iranian family with congenital fibrosis of extraocular muscles type 2 (CFEOM2). Am J Ophthalmol (2003) 0.93
Clear cell odontogenic carcinoma: evaluation of reported cases. J Oral Maxillofac Surg (2003) 0.91
Management of thyroid nodules with atypical cytology on fine-needle aspiration biopsy. Ann Surg Oncol (2012) 0.91
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 34-2003. A 45-year-old woman with a family history of colonic polyps and cancer. N Engl J Med (2003) 0.90
Endoscopic surveillance of patients with hereditary diffuse gastric cancer: biopsy recommendations after topographic distribution of cancer foci in a series of 10 CDH1-mutated gastrectomies. Am J Surg Pathol (2012) 0.90
In vivo detection of experimental optic neuritis by pupillometry. Exp Eye Res (2012) 0.89
Synovial chondromatosis of the temporomandibular joint: report and analysis of eleven cases. J Oral Maxillofac Surg (2005) 0.89
Application of molecular diagnostics for the detection of Lynch syndrome. Expert Rev Mol Diagn (2010) 0.89